3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Lung Neoplasms
5
Prostatic Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Paranasal Sinus Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Maxillary Sinus Neoplasms
1
Lymphoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Fasting
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
8
Nivolumab
6
Gemcitabine
5
spartalizumab
3
Magnetic Resonance Spectroscopy
3
Cyclophosphamide
3
Azacitidine
3
toripalimab
2
fludarabine
2
epacadostat
2
atezolizumab
2
Therapeutics
2
Sirolimus
2
Paclitaxel
2
Interleukin-2
2
Epoetin Alfa
2
Cisplatin
2
Bevacizumab
2
vocimagene amiretrorepvec
1
vandetanib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
tislelizumab
1
temsirolimus
1
sargramostim
1
sapanisertib
1
ruxolitinib
1
rucaparib
1
romidepsin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Referral and Consultation
×
Thoracic
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts